MetLife Investment Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
2,887
-95,999
| -97% | -$3.53M | ﹤0.01% | 2513 |
|
|
2025
Q1 | $3.5M | Sell |
98,886
-1,443
| -1% | -$51K | 0.02% | 792 |
|
|
2024
Q4 | $4.39M | Buy |
100,329
+13,918
| +16% | +$609K | 0.02% | 636 |
|
|
2024
Q3 | $3.92M | Sell |
86,411
-1,501
| -2% | -$68.1K | 0.02% | 669 |
|
|
2024
Q2 | $3.41M | Buy |
87,912
+16,705
| +23% | +$648K | 0.02% | 709 |
|
|
2024
Q1 | $2.3M | Sell |
71,207
-4,190
| -6% | -$135K | 0.02% | 898 |
|
|
2023
Q4 | $2.16M | Buy |
75,397
+21,936
| +41% | +$629K | 0.02% | 919 |
|
|
2023
Q3 | $1.48M | Hold |
53,461
| – | – | 0.01% | 1035 |
|
|
2023
Q2 | $1.43M | Buy |
53,461
+7,885
| +17% | +$211K | 0.01% | 1075 |
|
|
2023
Q1 | $987K | Buy |
45,576
+6,059
| +15% | +$131K | 0.01% | 1228 |
|
|
2022
Q4 | $941K | Hold |
39,517
| – | – | 0.01% | 1251 |
|
|
2022
Q3 | $779K | Buy |
39,517
+5,261
| +15% | +$104K | 0.01% | 1319 |
|
|
2022
Q2 | $668K | Hold |
34,256
| – | – | 0.01% | 1469 |
|
|
2022
Q1 | $874K | Buy |
34,256
+12,643
| +58% | +$323K | 0.01% | 1415 |
|
|
2021
Q4 | $544K | Hold |
21,613
| – | – | ﹤0.01% | 1458 |
|
|
2021
Q3 | $595K | Hold |
21,613
| – | – | 0.01% | 1428 |
|
|
2021
Q2 | $686K | Buy |
21,613
+4,956
| +30% | +$157K | 0.01% | 1388 |
|
|
2021
Q1 | $764K | Hold |
16,657
| – | – | 0.01% | 1279 |
|
|
2020
Q4 | $659K | Hold |
16,657
| – | – | 0.01% | 1335 |
|
|
2020
Q3 | $580K | Buy |
16,657
+9,645
| +138% | +$336K | 0.01% | 1296 |
|
|
2020
Q2 | $221K | Hold |
7,012
| – | – | ﹤0.01% | 1850 |
|
|
2020
Q1 | $154K | Buy |
+7,012
| New | +$154K | ﹤0.01% | 1838 |
|